Showing results (281-290 of 499) with videos related to
Sort By:
Pageof 50
Annals of Clinical and Translational Neurology|August 11, 2022
Glial fibrillary acidic protein in cerebrospinal fluid of patients with spinal muscular atrophyMaren Freigang, Petra Steinacker, Claudia D Wurster, et al.JAMA Network Open|February 10, 2026
Blood-Based Analysis of Different Tau Variants in Patients With Multiple Traumatic InjuriesRebecca Halbgebauer, Fernando Gonzalez-Ortiz, Benjamin Mayer, et al.Journal of Neurology, Neurosurgery, and Psychiatry|December 31, 2020
Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer's diseaseSteffen Halbgebauer, Patrick Oeckl, Petra Steinacker, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 5, 2026
Increased transmembrane protein 119 (TMEM119) levels in the cerebrospinal fluid of patients with mild cognitive impairment due to Alzheimer's disease suggest early microglial involvementPaula Klassen, Christoforos Alexudis, Veronika Klose, et al.Therapeutic Advances in Neurological Disorders|February 2, 2026
Aspiration, stent retriever, or combined approach for basilar artery occlusion: a three-way comparative analysisMuhammad Jaffar, Kazi Ahmed, Samir Abu-Rumeileh, et al.Journal of Neurology|September 26, 2019
Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersenClaudia D Wurster, Petra Steinacker, René Günther, et al.Cells|April 30, 2021
Protein Binding Partners of Dysregulated miRNAs in Parkinson's Disease SerumWolfgang P Ruf, Axel Freischmidt, Veselin Grozdanov, et al.Neurology(R) Neuroimmunology & Neuroinflammation|October 8, 2025
CSF Beta-Synuclein, SNAP-25, and Neurogranin in Infectious and Autoimmune Inflammatory Neurologic DiseasesSamir Abu-Rumeileh, Deborah K Erhart, Lorenzo Barba, et al.Scientific Reports|November 28, 2023
Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic strokeLorenzo Barba, Christoph Vollmuth, Samir Abu-Rumeileh, et al.Acta Neuropathologica Communications|July 14, 2019
Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosisLaura Rué, Patrick Oeckl, Mieke Timmers, et al.Pageof 50